ALTASCIENCES’ EARLY-PHASE DRUG DEVELOPMENT RESEARCH FACILITIES
With nine research and development facilities strategically located across Canada and the U.S., Altasciences offers an integrated, comprehensive solution for all your early-phase drug development needs. From discovery to safety assessment, to clinical proof of concept and beyond, our teams move in unison to help you get better drugs to the people who need them, faster.
Ask our ExpertsOur Facilities
1200 Beaumont Avenue
Montreal, QC H3P 3P1
Canada 514 381-2546
PRECLINICAL TESTING FACILITIES
Altasciences’ four preclinical research facilities offer a full range of in vivo GLP and non-GLP evaluations for small and large molecules, in a wide range of species. Our sites feature 585,000 square feet of purpose-built space dedicated to comprehensive regulatory safety testing and bioanalysis, offering CRO services to support your drug development programs, from exploratory studies to regulatory submission.
Our team of skilled scientists and experts ensure quality data for your critical decisions, seamlessly advancing your lead compounds to first-in-human trials.
Learn more about our preclinical servicesCUSTOM-DESIGNED ANIMAL ROOMS
EXPERTS
SQ. FT.
SEATTLE, WASHINGTON
Altasciences’ researchers bring decades of experience to the table, specializing in small and large molecule GLP and non-GLP safety testing.
With in-house bioanalytical laboratories and an on-site, 4,500-square foot archive facility, our Seattle preclinical site is fully equipped to support both internal and external studies, and is located close to international and domestic airports.
- 160 custom-designed animal rooms, including
- Capacity to house ~3,680 NHPs, ~500 canines, ~12,000 rodents, and ~800 rabbits
- In-house bioanalytical laboratories to support internal and external studies
- On-site archive facility (~4,500 sq. ft.)
- 2,400+ safety studies performed to date
- 440 on-site experts
- Monoclonal antibodies
- Gene therapy
- Oligonucleotides
- Antibody drug conjugate in NHPs
- AAALAC
- USDA
- OLAW
- BSL-2
COLUMBIA, MISSOURI
Renowned for miniature swine research, and over 180 studies completed annually, our Columbia team has years of experience working with all rodent and non-rodent species.
Our preclinical facility can perform small and large molecule studies, safety testing, and features in-house bioanalytical laboratories to support internal and external studies.
The site is in proximity to Kansas City International Airport and St. Louis Lambert International Airport.
- 80 custom-designed animal rooms
- Capacity to house ~200 NHPs, ~700 canines, ~800 swine, ~2,320 rodents, ~300 guinea pigs, and ~100 rabbits
- In-house bioanalytical laboratories support clinical studies
- Over 270 on-site experts
- Miniature swine research, including juvenile toxicology
- Dermal studies
- Non-rodent surgery
- AAALAC
- USDA
- PHS
- DEA registered Schedule II-V
SCRANTON, PENNSYLVANIA
Our Scranton preclinical site conducts over 350 safety studies each year, leveraging expertise in drug discovery, pharmacological research, and ocular therapies.
The site features an 1,840-square foot archive facility, and is located around 23 minutes of Scranton/Wilkes-Barre International Airport.
- 40 animal rooms
- Capacity to house ~140 NHPs, ~350 canines, ~350 swine, ~6,500 rodents, and ~800 rabbits
- Archive facility (1,840 sq. ft.)
- In-house bioanalytical laboratory
- 85 in-house experts
- Small molecules
- Efficacy pharmacology
- Ophthalmology
- AAALAC
- USDA
- PHS
- DEA registered Schedule II-V
SACRAMENTO, CALIFORNIA
With decades of experience and expertise in biomedical and behavorial research, our Sacramento, CA, preclinical facility specializes in translational research in NHPs.
Our 31,000-square-foot site is located close to San Francisco International, Oakland International, Buchanan Field Domestic, and Napa County Domestic airports.
- 18 animal rooms
- capacity to house ~850 NHPs
- CDC quarantine area
- AAALAC
- USDA
- CDC
- OLAW
PHASE 1 CLINICAL TRIAL UNITS
Our three clinical trial facilities include adaptive clinical pharmacology units for Phase I and II studies in healthy normal volunteers (HNV) and patient populations for small and large molecules.
We complete over 285 clinical trials each year, including specialized assessments—such as driving simulation, and human abuse potential.
Our Phase I clinical trial units are flexible and adjustable for single- or multi-site clinical trials. For long or short stays, our units have a team of experts to conduct trials in a range of therapeutic areas. With dedicated in-house USP 797 pharmacies, we are the single-source solution to your small and large molecule early-phase clinical trial needs.
Learn more about our clinical servicesBEDS IN NORTH AMERICA
ACTIVE PARTICIPANTS
SQ. FT.
Los Angeles, California
Our Los Angeles clinical pharmacology unit has facilitated over 600 clinical trials, and is renowned for its Asian ethnobridging capabilities, having conducted over 200 ethnobridging studies since 2004.
With 180 beds, this site is located close to Los Angeles International, Long Beach Domestic, and John Wayne airports.
- PBMC processing
- Dedicated USP 797 pharmacy with cleanroom
- On-site CAP and CLIA-accredited safety reference laboratories
- 55,000+ database of active participants
- 180+ in-house experts
- Known industry-wide for Asian ethnobridging capabilities
- Principal Investigators with anesthesiology and urology specializations
- Multilingual participant recruitment team
KANSAS CITY, KANSAS
Having accommodated over 7,000 clinical trials our clinical research site in Kansas City comprises a 140-bed unit, including a specialized 36-bed secure access area for sequestering patient populations. The facility is run by over 190 trained personnel, and is specifically designed to recruit and retain participants for overnight stays.
The facility is less than an hour’s drive from Kansas City International Airport.
- Dedicated USP 797 pharmacy with cleanroom
- Dedicated QT unit, ECGs, and Holter monitors
- PBMC processing clinical studies
- 140-bed unit
- 45,000+ database of active participants
- Neurological/CNS studies, particularly HAP
- Long-term stays
- Principal Investigators with psychiatry and epidemiology specializations
MONTRÉAL, QUÉBEC
With over 50,000 active participants, the Montréal facility has hosted more than 2,850 clinical trials, connecting you with specialized and patient populations for proof-of-concept (POC) studies.
Strategically located 15 minutes from our bioanalytical facility in Greater Montréal, QC, this site is also less than 30 minutes from Montréal-Pierre Elliott Trudeau International Airport.
- Dedicated USP 797 pharmacy with cleanroom
- Seven individual specialized units
- Co-located ophthalmology clinic
- Large, customizable clinical pharmacology unit
- Neurological/CNS studies—human abuse potential (HAP), cognition, pain, etc.
- Ophthalmology
- 10 on-site driving simulators
- Principal Investigators with gastrointestinal and ophthalmology specializations, and general practitioners
MANUFACTURING AND ANALYTICAL TESTING FACILITY
Our manufacturing and analytical services campus offers formulation development, Phase I through commercial manufacturing, and ICH stability storage and testing. We also perform analytical method development, qualification, and validation at the facility, as well as finished product and release testing. We have formulated, tested, and/or manufactured nearly every pharmaceutical dosage form on the market today.
Learn more about our contract development and manufacturing servicesSTAFF MEMBERS
SQ. FT.
LICENCE FOR SCHEDULE I-V
PHILADELPHIA, PENNSYLVANIA
Featuring ISO 7 and IS0 state-of-the-art cleanrooms, our fully qualified, FDA-inspected manufacturing facility features an analytical lab, R&D formulations lab, multiple manufacturing suites, and a cGMP warehouse. The site is less than an hour’s drive from both Philadelphia International, and Lehigh Valley International airports.
- State-of-the-art Grade C and Grade D cleanrooms
- Client-dedicated space and equipment
- DEA license for drugs and controlled
- Substances Schedule I-V, including pallet positions for Schedule III-V, and vaults for Schedule I-II
- Environmental monitoring system
- Formulation development and manufacturing of most dosage forms
- In-house analytical testing
- ICH stability testing
- Phase I, II, and III clinical supply and commercial manufacturing
- Bottle and blister packaging and package design
LEADING-EDGE BIOANALYTICAL LABORATORIES
Our state-of-the-art laboratories are equipped with instrumentation to support all your bioanalytical needs. From the quantitation of drugs, metabolites and biomarkers, to immunogenicity, bioanalysis is routinely conducted to support preclinical and clinical studies conducted at our facilities and worldwide.
Our laboratories are strategically located and uniformly designed to support an integrated workflow. This design ensures timely collection, processing, transport, and rapid analysis of your samples.
Learn more about our bioanalytical servicesASSAYS
EXPERTS
SQ. FT.
GREATER MONTRÉAL, QUÉBEC, CANADA
With 200 highly skilled bioanalytical experts experienced in small and large molecule method development, validation, and sample analysis services, our Greater Montréal scientific laboratory can offer solutions spanning discovery to preclinical to Phase IV.
This dedicated bioanalytical facility is only 15 minutes from our Montréal clinical facility, in proximity to Montréal-Pierre Elliott Trudeau International Airport.
- 18,792 sq. ft. of laboratory space
- In-house storage and sample management
- Sample storage at room temperature (22 °C), 4 °C, -20 °C, -80 °C, and cryogenic capabilities (-196 °C)
- Watson LIMS
- Ability to support worldwide sample shipments
- 685+ assays covering 650+ molecules
- Flow cytometry
- Microsampling
- Immunogenicity
- Biomarkers
- Cell-based assays
- CL2 areas and experience working with infectious samples
- Ligand binding assays
- Hybrid mass spectrometry and ligand binding assays
- PBMC isolation
- Mass spectrometry
SEATTLE, WASHINGTON
Our 4,000-square foot bioanalytical laboratory is located within our preclinical facility in Seattle, and is specially designed to support both internal and external studies. The Seattle facility is located within six minutes of Paine Field Airport, and 20 minutes from Harvey Airfield.
- In-house storage and sample management
- Sample storage at room temperature (22 °C), 4 °C, -20 °C, -80 °C, and cryogenic capabilities (-196 °C)
- Watson LIMS
- Ability to support worldwide sample shipments
- CL2 areas and experience working with infectious samples
- PCR
- Flow cytometry
- Immunogenicity
- Biomarkers
- Mass spectrometry
- Ligand binding assays
- PBMC isolation
- Cell-based assays
COLUMBIA, MISSOURI
Our 4,000-sq. ft. bioanalytical laboratory is situated within our preclinical facility in Missouri to support internal and external preclinical and clinical studies. The site has a proven track record in handling infectious samples and offers a range of services, including mass spectrometry, ligand binding assays, flow cytometry, biomarker analysis, and cell culture.
The Columbia site is located approximately 30 minutes from Columbia Regional Airport.
- In-house storage and sample management
- In-house bioanalytical laboratories to support internal and external studies
- Sample storage at room temperature (22 °C), 4 °C, -20 °C, -80 °C, and cryogenic capabilities (-196 °C)
- Ability to support worldwide sample shipments
- Watson LIMS
- CL2 areas and experience working with infectious samples
- PCR
- Flow cytometry
- Immunogenicity
- Microsampling
- Biomarkers
- Ligand binding assays
- PBMC isolation
- Cell-based assays
REQUEST AN IN-PERSON OR VIRTUAL TOUR
Discover Altasciences’ state-of-the-art drug development and research facilities with a virtual or in-person tour.